Telaprevir News and Research

RSS
HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

Anti-viral drug telaprevir improves response, halves duration of hepatitis C treatment

Anti-viral drug telaprevir improves response, halves duration of hepatitis C treatment

Vertex Pharmaceuticals completes acquisition of ViroChem Pharma

Vertex Pharmaceuticals completes acquisition of ViroChem Pharma

Global drug research programme comes to Diamond in Oxfordshire

Global drug research programme comes to Diamond in Oxfordshire

New drug therapy zaps hepatitis C in 12 weeks

New drug therapy zaps hepatitis C in 12 weeks